This acquisition, valued at $8bn, was presented as a way for Illumina, a company that makes gene sequencing machines to corner a new market in the realm of cancer screening and detection.

此次收购价值 80 亿美元，是 Illumina 公司抢占癌症筛查和检测领域新市场的一种方式。 Illumina 是一家生产基因测序仪的公司。